761 related articles for article (PubMed ID: 34638609)
1. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
3. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming Tumor Blood Vessels for Enhancing Immunotherapy.
Schmittnaegel M; De Palma M
Trends Cancer; 2017 Dec; 3(12):809-812. PubMed ID: 29198436
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies.
Dong Y; Wan Z; Gao X; Yang G; Liu L
Front Immunol; 2021; 12():609762. PubMed ID: 33968014
[TBL] [Abstract][Full Text] [Related]
6. Blocking inflammation to improve immunotherapy of advanced cancer.
Macciò A; Madeddu C
Immunology; 2020 Apr; 159(4):357-364. PubMed ID: 31821533
[TBL] [Abstract][Full Text] [Related]
7. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
Li X; Xu W
Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
Kishton RJ; Sukumar M; Restifo NP
Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
[TBL] [Abstract][Full Text] [Related]
10. Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy.
Bahrambeigi S; Molaparast M; Sohrabi F; Seifi L; Faraji A; Fani S; Shafiei-Irannejad V
Immunol Lett; 2020 Apr; 220():32-37. PubMed ID: 31982460
[TBL] [Abstract][Full Text] [Related]
11. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
12. Cell Fate Reprogramming in the Era of Cancer Immunotherapy.
Zimmermannova O; Caiado I; Ferreira AG; Pereira CF
Front Immunol; 2021; 12():714822. PubMed ID: 34367185
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional T cell metabolism in the tumor microenvironment.
Beckermann KE; Dudzinski SO; Rathmell JC
Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
15. Metabolic checkpoints and novel approaches for immunotherapy against cancer.
Li Y; Tang J; Jiang J; Chen Z
Int J Cancer; 2022 Jan; 150(2):195-207. PubMed ID: 34460110
[TBL] [Abstract][Full Text] [Related]
16. Integrating T cell metabolism in cancer immunotherapy.
Dugnani E; Pasquale V; Bordignon C; Canu A; Piemonti L; Monti P
Cancer Lett; 2017 Dec; 411():12-18. PubMed ID: 28974448
[TBL] [Abstract][Full Text] [Related]
17. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
Front Immunol; 2018; 9():2250. PubMed ID: 30349530
[TBL] [Abstract][Full Text] [Related]
18. CCL21 Programs Immune Activity in Tumor Microenvironment.
Sharma S; Kadam P; Dubinett S
Adv Exp Med Biol; 2020; 1231():67-78. PubMed ID: 32060847
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Immune Cell Functions by Metabolic Reprogramming.
Kim J
J Immunol Res; 2018; 2018():8605471. PubMed ID: 29651445
[TBL] [Abstract][Full Text] [Related]
20. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]